{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:46:02Z","timestamp":1776660362613,"version":"3.51.2"},"reference-count":50,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:p>The Norbert Freinkel Award recognizes contribution of research, clinical practice, and advocacy to improving pregnancy outcomes for women with diabetes. This award honors a man of outstanding achievements. Norbert was a forward-thinking investigator, a concise and precise writer, and a gifted clinical practitioner. His philosophy stated that a research question should be framed around an unsolved patient problem, a solution should be sought at several levels and across several disciplines, and the solution should be shared and applied to the problem. The Atlantic Diabetes in Pregnancy (ATLANTIC DIP) network has followed this philosophy. Women now achieve better pregnancy preparation and have lower blood glucose and lower glycated hemoglobin with improved pregnancy outcomes. Screening and follow-up for gestational diabetes mellitus (GDM) is consistent. The trial on early metformin in addition to usual care in the reduction of GDM effects (A Randomized Placebo-Controlled Trial of the Effectiveness of Metformin in Addition to Usual Care in the Reduction of Gestational Diabetes Mellitus Effects [EMERGE]) provides evidence for metformin use in pregnancies complicated by GDM as an alternative to insulin. Learnings and evidence from ATLANTIC DIP have shaped national policy and guidelines and have contributed to global knowledge in this area. We continue to strive for excellence and equity of care and normalization of perinatal outcomes.<\/jats:p>","DOI":"10.2337\/dci24-0047","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T19:55:16Z","timestamp":1742586916000},"page":"499-508","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["ATLANTIC DIP, Changing the Landscape for Better Maternal and Infant Health: The 2024 Norbert Freinkel Award Lecture"],"prefix":"10.2337","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3682-9403","authenticated-orcid":false,"given":"Fidelma","family":"Dunne","sequence":"first","affiliation":[{"name":"Institute for Clinical Trial, Clinical Science Institute, University of Galway, Galway, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025032119023298200_B1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2337\/dc09-1118","article-title":"ATLANTIC DIP: pregnancy outcome for women with pregestational diabetes along the Irish Atlantic seaboard","volume":"32","author":"Dunne","year":"2009","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.285.6338.353","article-title":"Five years' experience of a \u201cprepregnancy\u201d clinic for insulin-dependent diabetics","volume":"285","author":"Steel","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2025032119023298200_B3","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2337\/dc05-2265","article-title":"Prepregnancy care and pregnancy outcomes in women with type 1 diabetes","volume":"29","author":"Temple","year":"2006","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B4","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/dc10-1113","article-title":"Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control","volume":"33","author":"Murphy","year":"2010","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B5","unstructured":"Dunne\n              F.\n            \n           Pregnancy and Diabetes. Accessed 3 February 2025. Available from https:\/\/www.whatsupmum.ie\/diabetes\/"},{"key":"2025032119023298200_B6","unstructured":"National Institute for Health and Care Excellence\n          . Diabetes in Pregnancy: Management From Preconception to the Postnatal Period. Published 25 February 2015. Updated 16 December 2020. Available from https:\/\/www.nice.org.uk\/guidance\/ng3"},{"key":"2025032119023298200_B7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/qjmed\/hcv060","article-title":"The management of type 1 and type 2 diabetes in pregnancy","volume":"108","author":"Egan","year":"2015","journal-title":"QJM"},{"key":"2025032119023298200_B8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/jc.2015-4046","article-title":"A prepregnancy care program for women with diabetes: effective and cost saving","volume":"101","author":"Egan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025032119023298200_B9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc12-0120","article-title":"ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes","volume":"35","author":"Owens","year":"2012","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12884-015-0499-y","article-title":"Comparing type 1 and type 2 diabetes in pregnancy\u2013similar conditions or is a separate approach required?","volume":"15","author":"Owens","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025032119023298200_B11","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.2015-3817","article-title":"Ten years of optimizing outcomes for women with type 1 and type 2 diabetes in pregnancy\u2014the Atlantic DIP experience","volume":"101","author":"Owens","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025032119023298200_B12","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/dme.13923","article-title":"An Irish national diabetes in pregnancy audit: aiming for best outcomes for women with diabetes","volume":"37","author":"Egan","year":"2020","journal-title":"Diabet Med"},{"key":"2025032119023298200_B13","doi-asserted-by":"crossref","first-page":"108685","DOI":"10.1016\/j.diabres.2021.108685","article-title":"Diabetes care and pregnancy outcomes for women with pregestational diabetes in Ireland","volume":"173","author":"Newman","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2025032119023298200_B14","doi-asserted-by":"crossref","first-page":"310239","DOI":"10.1155\/2015\/310239","article-title":"Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes","volume":"2015","author":"Egan","year":"2015","journal-title":"J Diabetes Res"},{"key":"2025032119023298200_B15","unstructured":"Health Service Executive\n          . Diabetic RetinaScreen in Pregnancy. Updated 12 June 2023. Accessed 3 February 2025. Available from https:\/\/www2.hse.ie\/conditions\/diabetic-retina-screening\/pregnancy\/"},{"key":"2025032119023298200_B16","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s00125-011-2150-4","article-title":"Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria","volume":"54","author":"O\u2019Sullivan","year":"2011","journal-title":"Diabetologia"},{"key":"2025032119023298200_B17","article-title":"Investigating the role of healthcare centre accessibility on the decision to attend for screening for gestational diabetes mellitus in Ireland","author":"Cullinan"},{"key":"2025032119023298200_B18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.diabres.2016.04.023","article-title":"Screening for gestational diabetes mellitus in primary versus secondary care: the clinical outcomes of a randomised controlled trial","volume":"117","author":"O\u2019Dea","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"2025032119023298200_B19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00125-015-3824-0","article-title":"The cost-effectiveness of screening for gestational diabetes mellitus in primary and secondary care in the Republic of Ireland","volume":"59","author":"Danyliv","year":"2016","journal-title":"Diabetologia"},{"key":"2025032119023298200_B20","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.2337\/dc12-2669","article-title":"Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change?","volume":"36","author":"Avalos","year":"2013","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B21","unstructured":"World Health Organization\n          . Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. 2013. Accessed 3 February 2025. Available from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/85975\/WHO_NMH_MND_13.2_eng.pdf?sequence=1"},{"key":"2025032119023298200_B22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1530\/EJE-11-0663","article-title":"Atlantic DIP: high prevalence of abnormal glucose tolerance post partum is reduced by breast-feeding in women with prior gestational diabetes mellitus","volume":"165","author":"O\u2019Reilly","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2025032119023298200_B23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-15-1260","article-title":"Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria","volume":"175","author":"Noctor","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2025032119023298200_B24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/EJE-13-0491","article-title":"ATLANTIC DIP: simplifying the follow-up of women with previous gestational diabetes","volume":"169","author":"Noctor","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2025032119023298200_B25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc13-2248","article-title":"The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort","volume":"37","author":"Chakera","year":"2014","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2337\/dc09-0911","article-title":"ATLANTIC DIP: the impact of obesity on pregnancy outcome in glucose-tolerant women","volume":"33","author":"Owens","year":"2010","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/s12884-020-03335-7","article-title":"Monitoring gestational weight gain and prepregnancy BMI using the 2009 IOM guidelines in the global population: a systematic review and meta-analysis","volume":"20","author":"Mart\u00ednez-Hortelano","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025032119023298200_B28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/jc.2013-2684","article-title":"ATLANTIC-DIP: excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus","volume":"99","author":"Egan","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025032119023298200_B29","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/jc.2015-3259","article-title":"Treatment with diet and exercise for women with gestational diabetes mellitus diagnosed using IADPSG criteria","volume":"100","author":"Kgosidialwa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025032119023298200_B30","first-page":"849","article-title":"ATLANTIC DIP: insulin therapy for women with IADPSG-diagnosed gestational diabetes mellitus","volume":"102","author":"Bogdanet","year":"2017","journal-title":"Does it work? J Clin Endocrinol Metab"},{"key":"2025032119023298200_B31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1186\/s13063-022-06694-y","article-title":"A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol","volume":"23","author":"Dunne","year":"2022","journal-title":"Trials"},{"key":"2025032119023298200_B32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2023.19869","article-title":"Early metformin in gestational diabetes: a randomized clinical trial","volume":"330","author":"Dunne","year":"2023","journal-title":"JAMA"},{"key":"2025032119023298200_B33","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1007\/s00125-024-06252-y","article-title":"Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE)","volume":"67","author":"Dunne","year":"2024","journal-title":"Diabetologia"},{"key":"2025032119023298200_B34","unstructured":"Health Service Executive\n          . Diabetes in Pregnancy: A Model of Care for Ireland2024. Accessed 3 February 2025. Available from https:\/\/www.hse.ie\/eng\/about\/who\/cspd\/ncps\/diabetes\/moc\/diabetes-in-pregnancy-a-model-of-care-for-ireland.pdf"},{"key":"2025032119023298200_B35","unstructured":"Health Service Executive\n          . Annual Chronic Disease Management Prevention Programme. Accessed 3 February 2025. Available from https:\/\/www.hse.ie\/eng\/services\/list\/2\/primarycare\/chronic-disease-management-programme\/annual-chronic-disease-management-prevention-programme.html"},{"key":"2025032119023298200_B36","unstructured":"Health Service Executive\n          . National Screening Advisory Committee. Accessed 15 August2024. Available from https:\/\/www.gov.ie\/en\/campaigns\/nsac\/"},{"key":"2025032119023298200_B37","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.2337\/dc20-1621","article-title":"Core outcome sets for studies of diabetes in pregnancy: a review","volume":"43","author":"Egan","year":"2020","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B38","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00125-017-4277-4","article-title":"A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes","volume":"60","author":"Egan","year":"2017","journal-title":"Diabetologia"},{"key":"2025032119023298200_B39","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00125-019-4935-9","article-title":"Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and\/or oral glucose-lowering agents: a core outcome set using a Delphi survey","volume":"62","author":"Bogdanet","year":"2019","journal-title":"Diabetologia"},{"key":"2025032119023298200_B40","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00125-020-05123-6","article-title":"A core outcome set for studies of gestational diabetes mellitus prevention and treatment","volume":"63","author":"Egan","year":"2020","journal-title":"Diabetologia"},{"key":"2025032119023298200_B41","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/1471-0528.16825","article-title":"A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study","volume":"128","author":"Kgosidialwa","year":"2021","journal-title":"BJOG"},{"key":"2025032119023298200_B42","doi-asserted-by":"crossref","first-page":"109879","DOI":"10.1016\/j.diabres.2022.109879","article-title":"Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: a systematic review","volume":"188","author":"Newman","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2025032119023298200_B43","first-page":"903","article-title":"Effect of physical activity and\/or healthy eating on GDM risk: the DALI lifestyle study","volume":"102","author":"Simmons","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025032119023298200_B44","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1464-5491.2011.03541.x","article-title":"Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review","volume":"29","author":"Buckley","year":"2012","journal-title":"Diabet Med"},{"key":"2025032119023298200_B45","first-page":"424010","article-title":"Associations of body mass index (maternal BMI) and gestational diabetes mellitus with neonatal and maternal pregnancy outcomes in a multicentre European database (diabetes and pregnancy vitamin D and lifestyle intervention for gestational diabetes mellitus prevention)","volume":"2012","author":"Vellinga","year":"2012","journal-title":"ISRN Obes"},{"key":"2025032119023298200_B46","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00125-017-4353-9","article-title":"Epidemiology of gestational diabetes mellitus according to IADPSG\/WHO 2013 criteria among obese pregnant women in Europe","volume":"60","author":"Egan","year":"2017","journal-title":"Diabetologia"},{"key":"2025032119023298200_B47","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"2025032119023298200_B48","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.2337\/dc20-S014","article-title":"14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B49","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2337\/dc21-0472","article-title":"Risk of major congenital malformations or perinatal or neonatal death with insulin detemir versus other basal insulins in pregnant women with preexisting diabetes: the real-world EVOLVE study","volume":"44","author":"Mathiesen","year":"2021","journal-title":"Diabetes Care"},{"key":"2025032119023298200_B50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S2213-8587(22)00307-2","article-title":"Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial","volume":"11","author":"Mathiesen","year":"2023","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/48\/4\/499\/801917\/dci240047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/48\/4\/499\/801917\/dci240047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T19:56:11Z","timestamp":1742586971000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/48\/4\/499\/157998\/ATLANTIC-DIP-Changing-the-Landscape-for-Better"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,21]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci24-0047","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}